We are proud to announce that the House Committee on Oversight and Accountability Staff has published a report titled “The Role of Pharmacy Benefit Managers in Prescription Drug Markets,” which references Frier Levitt three times. The report underscores the Committee’s findings that Pharmacy Benefit Managers (PBMs) inflate prescription drug costs and interfere with patient care for their own financial gain.
The report highlights the following works by Frier Levitt:
- “OIG Audit of Federal Employee Pharmacy Benefits Plan Reveals Express Scripts Retained $44.9 Million in Overpayments and Unreported Rebates” by attorneys Dae Y. Lee and Terence Park.
- “Proposed Congressional Bill Seeks to Ban Spread Pricing in State Medicaid Plans” by attorneys Todd Mizeski and Conor McCabe.
- Our comprehensive DIR Fees practice page.
We are honored that our legal work has once again been recognized by the U.S. government. This acknowledgment underscores the importance of our mission to advocate for transparency and fairness in the healthcare and life sciences industries, influencing significant policy changes in the U.S.
Read the full report HERE.
